Insider at

04

Insider transactions

05
0 buys (P) 4 sells (S) Net: $-6,319,810 + 15 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

15 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Nov. 18, 2025 BBIO S 24,007 $65.23 $1,565,977 81,576 Indirect -22.74% Disposed 3.1% (price as of 2026-10-02)
Nov. 18, 2025 BBIO S 30,993 $66.05 $2,047,088 50,583 Indirect -37.99% Disposed 1.8% (price as of 2026-10-02)
Nov. 17, 2025 BBIO S 36,801 $66.63 $2,452,051 17,887 Direct -67.29% Disposed 0.9% (price as of 2026-10-02)
Nov. 17, 2025 BBIO S 3,798 $67.06 $254,694 14,089 Direct -21.23% Disposed 0.3% (price as of 2026-10-02)
May 2, 2025 BBIO S 100,000 $38.50 $3,850,000 105,583 Indirect -48.64% Disposed 74.7% (price as of 2026-10-02)
Dec. 30, 2021 BBIO P 1,500 $14.30 $21,450 48,099 Direct +3.22% Acquired 370.3% (price as of 2026-10-02)
Dec. 29, 2021 BBIO P 6,000 $12.90 $77,400 46,599 Direct +14.78% Acquired 421.3% (price as of 2026-10-02)
Dec. 3, 2021 ABCL P 86,938 $14.02 $1,218,871 86,938 Direct · Acquired -2.0% (price as of 2026-10-02)
Jan. 12, 2018 ABUS P 664,000 $100.00 $66,400,000 1,164,000 Indirect +132.80% Acquired -95.6% (price as of 2026-10-02)
Oct. 16, 2017 ABUS P 500,000 $100.00 $50,000,000 500,000 Indirect · Acquired -95.6% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 22, 2026 BBIO Stock Option (Right to Buy) Common Stock (5,277) $68.92 June 21, 2036 5,277 Acquired
June 20, 2025 BBIO Stock Option (Right to Buy) Common Stock (8,425) $41.73 June 19, 2035 8,425 Acquired
June 12, 2025 ABCL Share option (right to buy) Common Shares (238,864) $3.15 June 12, 2035 238,864 Acquired
June 21, 2024 BBIO Stock Option (Right to Buy) Common Stock (26,014) $27.36 June 20, 2034 26,014 Acquired
June 21, 2024 ABCL Share option (right to buy) Common Shares (163,934) $2.94 June 21, 2034 163,934 Acquired
June 21, 2023 BBIO Stock Option (right to buy) Common Stock (51,501) $16.75 June 21, 2033 51,501 Acquired
Dec. 1, 2022 ABCL Share Option (right to buy) Common Shares (47,231) $13.18 Dec. 1, 2032 47,231 Acquired
Sept. 15, 2022 ROIV Stock Option (Right to Buy) Common Shares (71,850) $3.50 Sept. 14, 2032 71,850 Acquired
June 22, 2022 BBIO Stock Option (right to buy) Common Stock (104,921) $8.45 June 22, 2032 104,921 Acquired
Dec. 3, 2021 ABCL Share Option (right to buy) Common Shares (91,325) $14.02 Dec. 3, 2031 91,325 Acquired
June 17, 2021 BBIO Stock Option (right to buy) Common Stock (38,895) $62.63 June 16, 2031 38,895 Acquired
June 23, 2020 BBIO Stock Option (Right to Buy) Common Stock (101,223) $32.62 June 22, 2030 101,223 Acquired
Jan. 12, 2018 ABUS Series A Participating Convertible Preferred Shares Common shares, no par value · Oct. 16, 2021 664,000 Acquired
Oct. 16, 2017 ABUS Series A Participating Convertible Preferred Shares Common shares, no par value · Oct. 16, 2021 500,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 1, 2021 ROIV Stock Option (Right to Buy)→ Common Shares (690,583) 690,583 Direct
June 25, 2020 BBIO Common Stock 40,599 Direct
June 25, 2020 BBIO Common Stock 205,583 Indirect
July 13, 2016 ABUS Common Shares, no par value 16,013,540 Indirect